Pulse Biosciences, Inc. Shareholders' Equity
Pulse Biosciences, Inc. (PLSE) had Shareholders' Equity of $99.50 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $99.50M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $66.30M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $80.66M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $92.69M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $99.50M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $66.30M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $80.66M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $92.69M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $104.49M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $118.45M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $114.86M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $79.13M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $26.97M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $36.29M 10-Q · filed 2025-08-12 | |
| 2023-12-31 | $44.36M 10-K · filed 2026-02-19 | |
| 2023-09-30 | $52.15M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $60.50M 10-Q · filed 2024-10-30 | |
| 2023-03-31 | -$10.67M 10-Q · filed 2024-08-19 | -$10.67M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$2.25M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $6.19M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $23.41M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $20.80M 10-Q · filed 2023-08-10 | |
| 2021-12-31 | $44.36M 10-Q · filed 2024-10-30 | $35.69M 10-K · filed 2022-03-31 |
| 2021-09-30 | $47.39M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $59.75M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $20.40M 10-Q · filed 2022-08-10 | |
| 2020-12-31 | $22.89M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $32.70M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $42.33M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $21.77M 10-Q · filed 2021-08-09 | |
| 2019-12-31 | $30.74M 10-K · filed 2023-03-31 | |
| 2019-09-30 | $40.98M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $49.86M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $59.11M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $66.33M 10-K · filed 2022-03-31 | |
| 2018-09-30 | $28.07M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $35.05M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $41.09M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $45.99M 10-K · filed 2021-03-12 | |
| 2017-09-30 | $49.94M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $24.16M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $27.33M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $25.30M 10-K · filed 2020-03-16 | |
| 2016-09-30 | $27.86M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $30.47M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $12.17M 10-Q · filed 2016-06-27 | |
| 2015-12-31 | $13.66M 10-K · filed 2018-03-16 | |
| 2014-12-31 | $16.07M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |